Breaking News

Eurofins Scientific Acquires Beacon Discovery

Expands its integrated drug discovery capabilities and expertise.

Author Image

By: Charlie Sternberg

Associate Editor

Eurofins Scientific, a leader in bioanalytical testing, has acquired Beacon Discovery, a preeminent drug discovery and contract research organization (CRO) focused on G-Protein Coupled Receptor (GPCR) research.   Beacon Discovery joins Eurofins Discovery, a CRO with a broad portfolio of validated in vitro pharmacology, ADMET, and chemistry services for integrated drug discovery solutions. The transaction is expected to close in the coming weeks upon fulfilment of customary closing conditions.   ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters